Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 10 Insulin Resistance 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Prostatic Neoplasms 4 Diabetes Mellitus, Type 2 4 Pancreatic Neoplasms 3 Diabetes Mellitus 3 Carcinoma, Non-Small-Cell Lung 3 Urinary Bladder Neoplasms 2 Metabolic Syndrome 2 Leukoplakia, Oral 2 Leukemia, Myeloid, Chronic-Phase 2 Inflammation 2 Carotid Intimal Medial Thickness 1 2 Breast Neoplasms 2 Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene 1 Sleep Apnea, Obstructive 1 Skin Neoplasms 1 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Pharmacokinetics of MDV3100 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Meningioma 1 Memory Disorders 1 Lung Neoplasms 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leukemia, Myeloid, Acute 1

Interventions

Carboplatin 345 Cisplatin 240 Paclitaxel 208 Radiotherapy 206 Pemetrexed 190 Docetaxel 170 Gemcitabine 158 pembrolizumab 146 Erlotinib Hydrochloride 111 Magnetic Resonance Spectroscopy 101 Etoposide 98 Bevacizumab 96 Specimen Handling 84 Nivolumab 77 durvalumab 73 Radiosurgery 73 Blood Specimen Collection 65 Drug Therapy 61 osimertinib 56 Vinorelbine 54 Gefitinib 50 Surveys and Questionnaires 48 atezolizumab 44 Biopsy 43 Irinotecan 42 Radiation 41 Topotecan 39 Standard of Care 38 Cyclophosphamide 38 Surgical Procedures, Operative 35

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Neoplasms × Pioglitazone × Clear all

NCT05919147 2025-07-04

TRACE-1

Pennington Biomedical Research Center

Phase 2 Active not recruiting

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡